{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T08:34:01Z","timestamp":1783758841699,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Program, Research Division, Khon Kaen University","award":["Project code RP65-1-Cannabis 001"],"award-info":[{"award-number":["Project code RP65-1-Cannabis 001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The efficacy of cannabinoids as appetite stimulants in chronic wasting disorders is well established; however, their role in systemic sclerosis (SSc) remains to be elucidated. We aimed to evaluate the efficacy of cannabis oil on appetite, inflammatory markers, quality of life (QoL), and adverse events in patients with SSc compared to placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A randomized placebo-controlled trial was conducted in 27 SSc patients with anorexia or malnutrition, according to sample size analysis. Patients with overlap connective tissue diseases, malignancies, or severe medical conditions were excluded. Participants were randomized 1:1 to receive either cannabis oil or placebo (two drops sublingual twice daily). The endpoints included changes in appetite grading using the visual analogue scale (VAS), body weight (BW), daily calorie intake, inflammatory markers, and QoL assessed using the EuroQol-5 Dimension (EQ-5D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen patients in each group completed the study (66.7% were female, and 77.9% had diffuse cutaneous SSc). The cannabinoid group trended toward greater improvements in appetite, satisfaction with eating, ability to eat more, BW, daily calorie intake, health VAS, and reduced inflammatory markers than the placebo group, although the differences were not statistically significant. Transferrin, transforming growth factor-\u03b2, and serum albumin levels did not differ between the groups. The VAS score for hunger significantly increased in the treatment group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) but not in the placebo group. One patient in the treatment group developed severe hyponatremia and was withdrawn from the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cannabis oil showed a trend toward improving appetite, BW, calorie intake, and QoL in SSc patients with anorexia, though most results were not statistically significant. Hunger VAS scores increased significantly, and inflammatory markers showed some reduction. Larger studies are needed to confirm these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>NCT05416697, registered on June 9, 2022.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-025-00342-3","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:31:39Z","timestamp":1761316299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial"],"prefix":"10.1186","volume":"7","author":[{"given":"Veeradej","family":"Pisprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bungon","family":"Sripanichkulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerawat","family":"Khannongpho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amonrat","family":"Jumnainsong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajanee","family":"Mahakkanukrauh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraphop","family":"Suwannaroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patnarin","family":"Pongkulkiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tippawan","family":"Onchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somdej","family":"Kanokmedhakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apichart","family":"So-ngern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chingching","family":"Foocharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"342_CR1","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/gut.2003.036350","volume":"53","author":"JH Allen","year":"2004","unstructured":"Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53:1566\u201370.","journal-title":"Gut"},{"key":"342_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.berh.2012.01.011","volume":"26","author":"A Balbir-Gurman","year":"2012","unstructured":"Balbir-Gurman A, Braun-Moscovici Y. Scleroderma - new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol. 2012;26:13\u201324.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"342_CR3","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3899\/jrheum.090694","volume":"36","author":"M Baron","year":"2009","unstructured":"Baron M, Hudson M, Steele R, Canadian Scleroderma Research Group. Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol. 2009;36:2737\u201343.","journal-title":"J Rheumatol"},{"key":"342_CR4","doi-asserted-by":"crossref","unstructured":"Blauwhoff-Buskermolen S, Ruijgrok C, Ostelo RW, de Vet HCW, Verheul HMW, de van der Schueren M et al. a. E, The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A\/CS and the VAS for appetite. Support Care Cancer. 2016;24:661\u20136.","DOI":"10.1007\/s00520-015-2826-2"},{"key":"342_CR5","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","volume":"22","author":"TD Brisbois","year":"2011","unstructured":"Brisbois TD, de Kock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, Chasen M, et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol. 2011;22:2086\u201393.","journal-title":"Ann Oncol"},{"key":"342_CR6","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.cgh.2023.07.031","volume":"21","author":"M Camilleri","year":"2023","unstructured":"Camilleri M, Zheng T. Cannabinoids and the gastrointestinal tract. Clin Gastroenterol Hepatol. 2023;21:3217\u201329.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"342_CR7","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"F Strasser","year":"2006","unstructured":"Cannabis-In-Cachexia-Study-Group, Strasser F, Luftner D, Possinger K, Ernst G, Ruhstaller T, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. J Clin Oncol. 2006;24:3394\u2013400.","journal-title":"J Clin Oncol"},{"key":"342_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.18433\/jpps31242","volume":"23","author":"L Cohen","year":"2020","unstructured":"Cohen L, Neuman MG. Cannabis and the gastrointestinal tract. J Pharm Pharm Sci. 2020;23:301\u201313.","journal-title":"J Pharm Pharm Sci"},{"key":"342_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/0003489415612801","volume":"125","author":"M C\u00f4t\u00e9","year":"2016","unstructured":"C\u00f4t\u00e9 M, Trudel M, Wang C, Fortin A. Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial. Ann Otol Rhinol Laryngol. 2016;125:317\u201324.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"342_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nn1457","volume":"8","author":"V Di Marzo","year":"2005","unstructured":"Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci. 2005;8:585\u20139.","journal-title":"Nat Neurosci"},{"key":"342_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ncp.10613","volume":"36","author":"DR Duerksen","year":"2021","unstructured":"Duerksen DR, Laporte M, Jeejeebhoy K. Evaluation of nutrition status using the subjective global assessment: malnutrition, cachexia, and sarcopenia. Nutr Clin Pract. 2021;36:942\u201356.","journal-title":"Nutr Clin Pract"},{"key":"342_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/sj.ijo.0801083","volume":"24","author":"A Flint","year":"2000","unstructured":"Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24:38\u201348.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"342_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","volume":"71","author":"EG Gonzalez","year":"2012","unstructured":"Gonzalez EG, Selvi E, Balistreri E, Akhmetshina A, Palumbo K, Lorenzini S, et al. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis. Ann Rheum Dis. 2012;71:1545\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"342_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/QAI.0b013e31811ed205","volume":"45","author":"M Haney","year":"2007","unstructured":"Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, et al. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr. 2007;45(5):545\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"342_CR15","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/rheumatology\/kes160","volume":"51","author":"E Harrison","year":"2012","unstructured":"Harrison E, Herrick AL, McLaughlin JT, Lal S. Malnutrition in systemic sclerosis. Rheumatology (Oxford). 2012;51:1747\u201356.","journal-title":"Rheumatology (Oxford)"},{"key":"342_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/can.2020.0105","volume":"6","author":"FR Henshaw","year":"2021","unstructured":"Henshaw FR, Dewsbury LS, Lim CK, Steiner GZ. The effects of cannabinoids on pro- and anti-inflammatory cytokines: a systematic review of in vivo studies. Cannabis Cannabinoid Res. 2021;6:177\u201395.","journal-title":"Cannabis Cannabinoid Res"},{"key":"342_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/ncp.10639","volume":"36","author":"S Johnson","year":"2021","unstructured":"Johnson S, Ziegler J, August DA. Cannabinoid use for appetite stimulation and weight gain in cancer care: does recent evidence support an update of the European society for clinical nutrition and metabolism clinical guidelines? Nutr Clin Pract. 2021;36:793\u2013807.","journal-title":"Nutr Clin Pract"},{"key":"342_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/09540260902782810","volume":"21","author":"TC Kirkham","year":"2009","unstructured":"Kirkham TC. Cannabinoids and appetite: food craving and food pleasure. Int Rev Psychiatry. 2009;21:163\u201371.","journal-title":"Int Rev Psychiatry"},{"key":"342_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nri1602","volume":"5","author":"TW Klein","year":"2005","unstructured":"Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol. 2005;5:400\u201311.","journal-title":"Nat Rev Immunol"},{"key":"342_CR20","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"342_CR21","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.jamda.2021.02.039","volume":"22","author":"V Malafarina","year":"2021","unstructured":"Malafarina V, Serra Rexach JA, Masan\u00e9s F, Cervera-D\u00edaz MC, Lample Lacasa L, Ollero Ortigas A, et al. Results of High-Protein, High-Calorie oral nutritional supplementation in malnourished older people in nursing homes: an Observational, Multicenter, Prospective, pragmatic study (PROT-e-GER). J Am Med Dir Assoc. 2021;22:1919\u201326. .e5.","journal-title":"J Am Med Dir Assoc"},{"key":"342_CR22","first-page":"49","volume":"8","author":"MB May","year":"2016","unstructured":"May MB, Glode AE. Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics. Cancer Manag Res. 2016;8:49\u201355.","journal-title":"Cancer Manag Res"},{"key":"342_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cgh.2013.04.034","volume":"11","author":"T Naftali","year":"2013","unstructured":"Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM. Cannabis induces a clinical response in patients with crohn\u2019s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol. 2013;11:1276\u2013e12801.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"342_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246871","volume":"16","author":"T Naftali","year":"2021","unstructured":"Naftali T, Bar-Lev Schleider L, Scklerovsky Benjaminov F, Konikoff FM, Matalon ST, Ringel Y. Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial. PLoS ONE. 2021;16:e0246871.","journal-title":"PLoS ONE"},{"key":"342_CR25","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4155\/fmc.09.93","volume":"1","author":"M Nagarkatti","year":"2009","unstructured":"Nagarkatti M, Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem. 2009;1:1333\u201349.","journal-title":"Future Med Chem"},{"key":"342_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2353\/ajpath.2010.090763","volume":"177","author":"A Servettaz","year":"2010","unstructured":"Servettaz A, Kavian N, Nicco C, Deveaux V, Ch\u00e9reau C, Wang A, et al. Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis. Am J Pathol. 2010;177:187\u201396.","journal-title":"Am J Pathol"},{"issue":"Suppl 4","key":"342_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/ard.50.Suppl_4.854","volume":"50","author":"RM Silver","year":"1991","unstructured":"Silver RM. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis. 1991;50(Suppl 4):854\u201361.","journal-title":"Ann Rheum Dis"},{"key":"342_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000782","volume":"4","author":"V Smith","year":"2018","unstructured":"Smith V, Scir\u00e8 CA, Talarico R, Airo P, Alexander T, Allanore Y, et al. Systemic sclerosis: state of the art on clinical practice guidelines. RMD Open. 2018;4:e000782.","journal-title":"RMD Open"},{"issue":"13","key":"342_CR29","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","volume":"81","author":"B Stella","year":"2021","unstructured":"Stella B, Baratta F, Della Pepa C, Arpicco S, Gastaldi D, Dosio F. Cannabinoid formulations and delivery systems: current and future options to treat pain. Drugs. 2021;81(13):1513\u201357.","journal-title":"Drugs"},{"key":"342_CR30","first-page":"3029","volume":"26","author":"JG Turcott","year":"2018","unstructured":"Turcott JG, Del Roc\u00edo Guillen N\u00fa\u00f1ez M, Flores-Estrada D, O\u00f1ate-Oca\u00f1a LF, Zatarain-Barr\u00f3n ZL, Barr\u00f3n F, et al. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. Support Care Cancer. 2018;26:3029\u201338.","journal-title":"Support Care Cancer"},{"key":"342_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-018-0656-x","volume":"22","author":"N Vadivelu","year":"2018","unstructured":"Vadivelu N, Kai AM, Kodumudi G, Sramcik J, Kaye AD. Medical marijuana: current concepts, pharmacological actions of cannabinoid receptor mediated activation, and societal implications. Curr Pain Headache Rep. 2018;22:3.","journal-title":"Curr Pain Headache Rep"},{"key":"342_CR32","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"342_CR33","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313:2456\u201373.","journal-title":"JAMA"},{"key":"342_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1073\/pnas.0912048107","volume":"107","author":"R Yoshida","year":"2010","unstructured":"Yoshida R, Ohkuri T, Jyotaki M, Yasuo T, Horio N, Yasumatsu K, et al. Endocannabinoids selectively enhance sweet taste. Proc Natl Acad Sci U S A. 2010;107:935\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"342_CR35","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1096\/fj.201600646R","volume":"30","author":"RB Zurier","year":"2016","unstructured":"Zurier RB, Burstein SH. Cannabinoids, inflammation, and fibrosis. FASEB J. 2016;30:3682\u20139.","journal-title":"FASEB J"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00342-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00342-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T14:31:41Z","timestamp":1761316301000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-025-00342-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00342-3","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Human Research Ethics Committee of Khon Kaen University approved the study protocol and the written informed consent per the Helsinki Declaration and the Good Clinical Practice Guidelines (HE641619). All methods were performed according to the Declaration of Helsinki, relevant guidelines, and regulations. Written informed consent was obtained from all eligible patients before enrolment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent to publication and grant the Publisher\u2019s exclusive license for full copyright.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Pisprasert V. declares that he has no competing interests.\u00a0Sripanichkulchai B. declares that she has no competing interests.\u00a0Khannongpho T. declares that he has no competing interests.\u00a0Jumnainsong A. declares that she has no competing interests.\u00a0Mahakkanukrauh A. declares that she has no competing interests.\u00a0Suwannaroj S. declares that he has no competing interests.\u00a0Pongkulkiat P. declares that she has no competing interests.\u00a0Onchan T. declares that she has no competing interests.\u00a0So-ngern A. declares that he has no competing interests.\u00a0Kanokmedhakul S. declares that he has no competing interests.\u00a0Foocharoen C. declares that she has no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}